When hyperphosphatemia is secondary to hypoparathyroidism, FGF23 levels usually increase to try to inhibit tubular phosphate reabsorption (28), as also illustrated there with increased FGF23 levels (that may also have been increased by active vitamin D analogs). This evidence concerns the gene FGF23 and hyperphosphatemia.